News
The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...
The California Public Employees’ Retirement System (CalPERS) has a new pharmacy benefits contract with CVS Caremark, the ...
CVS Health has secured a major healthcare deal, winning a multi-year pharmacy benefits contract with CalPERS, outbidding rival UnitedHealth. The deal marks a significant win for CVS's Caremark unit ...
Litigation over state power to regulate pharmacy benefit managers is far from over, even after the US Supreme Court bolstered ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
3d
New Scientist on MSNYou don't need to take drugs like Ozempic consistently to lose weightPeople who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Mark Zuckerberg and Meta's current and former executives have settled an $8 billion lawsuit over privacy violations, avoiding ...
CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...
The most important philosophy we have of AI is that AI will never make decisions. Period. So AI would help us collect the ...
For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results